Market Cap
₹365 Cr.
P/E
85.21
About
Dujodwala Products Ltd. is engaged in the manufacturing and supplying of Gum Rosin, Oil of Turpentine and their derivatives.The company's product range includes Gum Rosin,Turpentine Oil,Pine Oil,Terp… Read more
Dujodwala Products Ltd. is engaged in the manufacturing and supplying of Gum Rosin, Oil of Tu… Read more
Low
270
52W Range
High
475
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

5 Yes

Positive for this company

3 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
-9.87%
3yr Average
13.81%
5yr Average
25.88%
Net Profit Margin
Latest
-5.53%
3yr Average
10.15%
5yr Average
12.04%
ROCE
Latest
-6.31%
3yr Average
19.9%
5yr Average
36.23%
Debt to Equity
Latest
0.69
3yr Average
0.49
5yr Average
0.4
Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • Manufacturing Capacity - Camphor (MTPA)
    Peer Comparison
    Customers
    • Asian Paints Ltd.
    • Dabur India Ltd.
    • Emami Ltd.
    • Kansai Nerolac Paints Ltd.
    • Pidilite Industries Ltd.
    FAQs on Mangalam Organics Ltd. Business

    Dujodwala Products Ltd. specializes in the production and distribution of a wide range of chemical products including Gum Rosin, Turpentine Oil, and various resin derivatives used in industries such as paper, adhesives, and foundry.

    Mangalam Organics major competitors are Alufluoride, Oriental Carbon&Chem, Hind Organic Chem, A-1 Acid, Multibase India, Par Drugs & Chem., Evexia Lifecare.
    Market Cap of Mangalam Organics is ₹365 Crs.
    While the median market cap of its peers are ₹338 Crs.

    Mangalam Organics seems to be less financially stable compared to its peers.
    Altman Z score of Mangalam Organics is 2.74 and is ranked 6 out of its 8 competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis